BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28799218)

  • 1. Synergy and mechanism of action of α-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii.
    Pimchan T; Maensiri D; Eumkeb G
    Lett Appl Microbiol; 2017 Oct; 65(4):285-291. PubMed ID: 28799218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism and the mechanism of action of the combination of α-mangostin isolated from Garcinia mangostana L. and oxacillin against an oxacillin-resistant Staphylococcus saprophyticus.
    Phitaktim S; Chomnawang M; Sirichaiwetchakoon K; Dunkhunthod B; Hobbs G; Eumkeb G
    BMC Microbiol; 2016 Aug; 16(1):195. PubMed ID: 27566110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
    Mataracı Kara E; Yılmaz M; Özbek Çelik B
    J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae.
    Eumkeb G; Chukrathok S
    Phytomedicine; 2013 Feb; 20(3-4):262-9. PubMed ID: 23218402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics.
    Danes C; Navia MM; Ruiz J; Marco F; Jurado A; Jimenez de Anta MT; Vila J
    J Antimicrob Chemother; 2002 Aug; 50(2):261-4. PubMed ID: 12161409
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
    Khalil MAF; Moawad SS; Hefzy EM
    J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2005 Jul; 39(3):265-72. PubMed ID: 16358485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients.
    Owlia P; Azimi L; Gholami A; Asghari B; Lari AR
    Infez Med; 2012 Sep; 20(3):182-7. PubMed ID: 22992558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of ceftazidime-resistant Acinetobacter baumannii clonal complex 92 in Korea.
    Lee Y; Bae IK; Kim J; Jeong SH; Lee K
    J Appl Microbiol; 2012 Jun; 112(6):1207-11. PubMed ID: 22404202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Lee S; Razqan GS; Kwon DH
    Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.
    Li Y; Wang B; Lu F; Ahn J; Zhang W; Cai L; Xu J; Yin Y; Cao Q; Ren Z; He X
    Microbiol Spectr; 2022 Feb; 10(1):e0176821. PubMed ID: 35196792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.